About OBSOLETE: Renal cell carcinoma associated with neuroblastoma
OBSOLETE: Renal cell carcinoma associated with neuroblastoma is a rare disease catalogued by Orphanet (ORPHA:319314). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to OBSOLETE: Renal cell carcinoma associated with neuroblastoma trials.
Search ClinicalTrials.gov for "OBSOLETE: Renal cell carcinoma associated with neuroblastoma" or Orphanet code ORPHA:319314 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting OBSOLETE: Renal cell carcinoma associated with neuroblastoma trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for OBSOLETE: Renal cell carcinoma associated with neuroblastoma. Updated daily.